Stanford University School of Medicine is developing new continuing medical education (CME) courses for physicians which are free from influence from the pharmaceutical industry, despite being funded by a three-year, $3 million grant from Pfizer. But the move has not put to rest the ongoing controversy over how to fund US CME, in which doctors are required to participate on a regular basis.
According to Stanford, Pfizer will have no say in how the funds are spent. Rather, the funds will be used...